2013, pp 341-360
Date: 19 Oct 2012

Biotechnological and Medical Exploitations of Toxin-Antitoxin Genes and Their Components

* Final gross prices may vary according to local VAT.

Get Access


We review here the state of the art on the application of toxin–antitoxin pairs in biotechnology and medicine, touching on technologies that range from simple selection of recombinant DNA in the laboratory, to complex and ambitious therapeutic strategies that may become routine in the future.